CJC-1295 (DAC) source due diligence
CJC-1295 (DAC) research source checklist Canada
A Canadian RUO checklist for evaluating CJC-1295 with DAC source pages: DAC-modified GHRH analogue identity, the displayed 5 mg lot COA (COA-2025-5033), analytical method, stated fill, storage notes, and variant-lot record boundaries.
Route CJC-1295 (DAC) demand into a source record
CJC-1295 with DAC Canada searches are compound-specific, but the useful next step is still documentation: exact DAC-modified GHRH identity, the current 5 mg product and batch record, COA access, stated fill, storage notes, Canadian fulfillment context, and a saved URL before an order is considered.
Keep DAC, No-DAC, and GH-axis records separate
CJC-1295 (DAC) belongs in a DAC-specific source file distinct from the No-DAC variant and from Sermorelin. Material identity, mechanism lane, analytical evidence, and handling assumptions differ; similar catalogue placement is not evidence of equivalence.
CJC-1295 (DAC) certificate checkpoint: 22 October 2026
The linked certificate COA-2025-5033 labels the sample CJC-1295 (DAC) 5mg and identifies lot LNX-2512-6973 (printed with a leading #). It reports 99.87% purity, 4.88 mg detected quantity, appearance of white lyophilized powder, received 2025-12-08, and reported 2025-12-12. The 4.88 mg value is the reported sample result, not the 5 mg catalogue label and not a guaranteed quantity for every vial. Preserve both values in your receiving record; ask support for clarification if your laboratory requires a particular fill tolerance.
Read the method labels without filling in gaps
The analytical heading states HPLC-UV coupled with mass spectrometry, while the footer describes LC-MS/MS. The document includes chromatogram and mass-spectrometry panels, but this checklist does not reconcile those method descriptions or independently validate the results. Request the method report and analytical files if that distinction matters to your institution's acceptance criteria.
Re-check the trail when the lot changes
A familiar product name does not make a replacement lot equivalent. Re-open the product page, match the displayed batch reference to the current COA, confirm the stated fill, purity method, and storage language, and save any support clarification with the procurement record before returning to checkout.
What this page cannot establish
- The certificate states that its results apply only to the named lot. This dated checkpoint does not document a replacement lot, the No-DAC variant, a CJC-1295 and Ipamorelin blend, or any other material.
- A reported purity percentage is not a sterility or endotoxin result, clinical approval, or evidence of suitability for administration. This material is for laboratory research only, not human or animal use.
- Lynx Labs branding and its quality-assurance contact do not independently identify a testing laboratory. Request the testing laboratory's identity, accreditation and underlying reports if your institution requires them.
- The COA checklist tool helps identify missing fields; it cannot authenticate a certificate or replace laboratory verification.
Sources and verification paths
Use these records to verify identity and current documentation. Re-check live product records when the lot or variant changes.
Research-use-only FAQ
Does this certificate also cover CJC-1295 without DAC?
No. COA-2025-5033 names CJC-1295 with DAC and lot LNX-2512-6973. Do not apply its reported results to the No-DAC variant, a CJC-1295 and Ipamorelin blend, or another lot. Each needs its own matching product and certificate record.
Why does a 5 mg listing have 4.88 mg on its certificate?
The certificate labels the material as 5mg and separately reports 4.88 mg detected quantity for the tested sample. Those fields are not interchangeable. This page does not establish a fill tolerance or a quantity guarantee for other vials; request clarification before procurement if the difference affects your lab's requirements.
Is this a CJC-1295 (DAC) use guide?
No. This page is limited to research-use-only source evaluation: material identity, the displayed 5 mg lot COA, analytical method, stated fill, storage notes, Canadian fulfillment, and claim-boundary review.
What should be saved before comparing CJC-1295 (DAC) source pages?
Save the current product URL, exact material name (including with DAC), stated fill, visible lot or batch reference, COA path, purity method, storage language, support clarification if needed, and the date the record was checked.
Ready to inspect current records?
LynxLabs product pages are for research-use-only procurement review. They are not dosing guides, treatment recommendations, or personal-use protocols.
Shop now